miR-503-5p confers drug resistance by targeting PUMA in colorectal carcinoma

The development of multidrug-resistance (MDR) is a major contributor to death in colorectal carcinoma (CRC). Here, we investigated the possible role of microRNA (miR)-503-5p in drug resistant CRC cells. Unbiased microRNA array screening revealed that miR-503-5p is up-regulated in two oxaliplatin (OX...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Xu, Ke, Chen, Guo, Qiu, Yanyan, Yuan, Zeting, Li, Hongchang, Yuan, Xia, Sun, Jian, Xu, Jianhua, Liang, Xin, Yin, Peihao
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5400618/
https://ncbi.nlm.nih.gov/pubmed/28423513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15559
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados